学术成果与获奖情况
以第一作者或通讯作者发表学术论文20余篇，其中SCI论文14篇，在《Journal of Experimental & Clinical Cancer Research》和《American Journal of Cancer Research》等知名刊物上发表论文，影响因子总和超20分，并被多次引用。代表性论著：1.Liu TT, Liu XS, Zhang M, Liu XN, Zhu FX, Zhu FM, Ouyang SW, Li SB, Song CL, Sun HM, Lu S, Zhang Y, Lin J, Tang HM, Peng ZH. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway, Journal of Cancer Research and Clinical Oncology, 2018, 144(6): 1049-1063. 2.Han Y, Lu S, Yu FD, Liu XS, Sun HM, Wang JT, Zhu XW, Lu HJ, Hao Y, Wang J, Lin J, Zhou CZ, Tang HM, Peng ZH. A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers, Scientific reports, 2016, 6(37240). 3. Sun HM, Mi YS, Yu FD, Han Y, Liu XS,Lu S, Zhang Y, Zhao SL, Ye L, Liu TT, Yang DH, Sun XF, Qin XB, Zhou ZG, Tang HM, Peng ZH.SERPINA4 is a novel independent prognostic indicator and a potential therapeutic target for colorectal cancer, American Journal of Cancer Research, 2016, 6(8): 1636-1649. 4. Zhang Y, Zhang M, Yu FD, Lu S, Sun HM, Tang HM, Peng ZH. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer, Journal of Experimental & Clinical Cancer Research, 2015., 34(1):145. 5. Zhang M, Cui FF, Lu S, Lu HJ, Xue YM, Wang JT, Chen J, Zhao SL, Ma SF, Zhang Y, Yu Y, Peng ZH, Tang HM. Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer, Journal of Experimental & Clinical Cancer Research, 2015, 34(1):60.
